"I've been 95% safe": perspectives on HIV pre-exposure prophylaxis at a drug detoxification center: a qualitative study
Pre-exposure prophylaxis (PrEP) decreases human immunodeficiency virus (HIV) acquisition among persons who inject drugs (PWID); however, its uptake has been suboptimal. We explored HIV risk perceptions and PrEP interest among drug detoxification center patients in the context of the ongoing opioid o...
Saved in:
Published in: | AIDS care Vol. 35; no. 4; pp. 461 - 465 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Taylor & Francis
03-04-2023
Taylor & Francis Ltd |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Pre-exposure prophylaxis (PrEP) decreases human immunodeficiency virus (HIV) acquisition among persons who inject drugs (PWID); however, its uptake has been suboptimal. We explored HIV risk perceptions and PrEP interest among drug detoxification center patients in the context of the ongoing opioid overdose epidemic. We conducted in-depth interviews of patients (n = 24) and professional key informants (n = 10 physicians, case managers, nurses, and harm reduction educators), and thematic analysis of coded data. The mean age of participants (patients) was 37 years; 54% identified as male and 67% as White. Although 71% reported injecting drugs and 62% had condomless sex in the past 6 months, participants had mixed HIV risk perceptions, and some viewed PrEP as an undesirable indicator of elevated HIV risk. Nevertheless, many participants viewed drug detoxification as a first step towards embarking on a "healthier lifestyle," with some narratives identifying opportunities for delivering PrEP information and services in this setting. Opportunities exist to expand PrEP at drug detoxification centers, but initiatives are needed to educate patients and staff on indications and benefits of this prevention tool. Interventions are also needed to determine the best strategies for implementing PrEP adoption in this setting. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Judith A. Bernstein, PhD, Emeritus Professor, Boston University School of Public Health, Dept of Community Health Sciences, 801 Massachusetts Ave Crosstown Center, Boston MA 02118, P: 617-414-1415 Angela R. Bazzi, PhD, MPH, Dept of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Ave Crosstown Center, Boston MA 02118 Christina M. Gebel, MPH, Dept of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Ave Crosstown Center, Boston MA 02118 Eugene Massey, BA, Dept of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Ave Crosstown Center, Boston MA 02118, P: 617-638-5160 Carlos R. Sian, MPH, Section of Infectious Diseases, Boston Medical Center, 801 Massachusetts Ave. Crosstown Center, 2nd Floor Boston, MA 02118 |
ISSN: | 0954-0121 1360-0451 |
DOI: | 10.1080/09540121.2022.2031853 |